Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tüting

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
EMBO Reports|April 19, 2022
XIAP promotes melanoma growth by inducing tumour neutrophil infiltrationMila Daoud, Pia Nora Broxtermann, Fabian Schorn, et al.
The Journal of Investigative Dermatology|August 19, 2007
Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasisJoerg Wenzel, Bettina Peters, Sabine Zahn, et al.
Cancer Immunology, Immunotherapy : CII|June 30, 2009
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptideRonald C Hendrickson, Vito R Cicinnati, Andreas Albers, et al.
Nature|November 25, 2011
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph diseasePhilipp Koch, Peter Breuer, Michael Peitz, et al.
Oncogene|June 19, 2021
E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasionEleonora Ottina, Veera Panova, Laura Doglio, et al.
Science (New York, N.Y.)|June 9, 2007
Attenuation of allergic contact dermatitis through the endocannabinoid systemMeliha Karsak, Evelyn Gaffal, Rahul Date, et al.
Melanoma Research|November 14, 2023
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNISKatharina C Kähler, Dirk Debus, Gaston Schley, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 1, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centersNina Flatt, Corinna Kochanek, Yenny Angela, et al.
Cancer Research|July 13, 2011
Potent antitumor immunity generated by a CD40-targeted adenoviral vaccineBasav N Hangalapura, Dinja Oosterhoff, Jan de Groot, et al.
Nature Communications|November 5, 2015
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitmentStefanie Riesenberg, Angela Groetchen, Robert Siddaway, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
EMBO Reports|April 19, 2022
XIAP promotes melanoma growth by inducing tumour neutrophil infiltrationMila Daoud, Pia Nora Broxtermann, Fabian Schorn, et al.
The Journal of Investigative Dermatology|August 19, 2007
Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasisJoerg Wenzel, Bettina Peters, Sabine Zahn, et al.
Cancer Immunology, Immunotherapy : CII|June 30, 2009
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptideRonald C Hendrickson, Vito R Cicinnati, Andreas Albers, et al.
Nature|November 25, 2011
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph diseasePhilipp Koch, Peter Breuer, Michael Peitz, et al.
Oncogene|June 19, 2021
E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasionEleonora Ottina, Veera Panova, Laura Doglio, et al.
Science (New York, N.Y.)|June 9, 2007
Attenuation of allergic contact dermatitis through the endocannabinoid systemMeliha Karsak, Evelyn Gaffal, Rahul Date, et al.
Melanoma Research|November 14, 2023
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNISKatharina C Kähler, Dirk Debus, Gaston Schley, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 1, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centersNina Flatt, Corinna Kochanek, Yenny Angela, et al.
Cancer Research|July 13, 2011
Potent antitumor immunity generated by a CD40-targeted adenoviral vaccineBasav N Hangalapura, Dinja Oosterhoff, Jan de Groot, et al.
Nature Communications|November 5, 2015
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitmentStefanie Riesenberg, Angela Groetchen, Robert Siddaway, et al.
Pageof 16